SUBSCRIBE
SUBSCRIBE

Alnylam Pharmaceuticals

NEWS
Biotech Bay
Biotech Blossoms Anew
April 29, 2008
 · 
2 min read
Business
Shanghai GenePharma Licenses Alnylam Pharmaceuticals siRNA Patents
March 24, 2008
 · 
1 min read
Biotech Bay
Market Highlights: Summer Doldrums Interrupted by RNAi Investment Frenzy
August 1, 2007
 · 
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Adds To Pipeline, Again
January 9, 2007
 · 
1 min read
Biotech Bay
The Day In Review: Cephalon, Inc. Wins Second Indication For Fento
October 11, 2006
 · 
1 min read
The Day In Review: News On Multiple Sclerosis Drugs
September 28, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Pays $515 Million For AnorMED
September 26, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Threshold Pharmaceuticals, Inc. Crushed On Trial Failure
July 17, 2006
 · 
1 min read
Biotech Beach
The Day In Review: MGI PHARMA, INC. Sells Ex-US Dacogen Rights
July 6, 2006
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
FDA
Alnylam Announces U.S. Food and Drug Administration Has Granted Priority Review of the Lumasiran New Drug Application for the Treatment of Primary Hyperoxaluria Type 1
May 26, 2020
 · 
9 min read
Genetown
Alnylam Presents New Long-Term Results from Global Open-Label Extension Study of ONPATTRO® (patisiran) at the European Academy of Neurology Virtual Congress 2020
May 22, 2020
 · 
14 min read
Biotech Bay
Top Pharmaceutical Company Visionaries to Keynote Veeva Summit Online
May 21, 2020
 · 
4 min read
Genetown
Alnylam to Webcast Presentations at Upcoming May 2020 Investor Conferences
May 11, 2020
 · 
2 min read
Business
Alnylam Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Period Activity
May 6, 2020
 · 
32 min read
Business
Vir and Alnylam Identify RNAi Therapeutic Development Candidate, VIR-2703 (ALN-COV), Targeting SARS-CoV-2 for the Treatment of COVID-19
May 4, 2020
 · 
13 min read
Business
Alnylam to Webcast Conference Call Discussing First Quarter 2020 Financial Results
April 23, 2020
 · 
2 min read
FDA
Alnylam Receives Fast Track Designation for Vutrisiran for the Treatment of the Polyneuropathy of hATTR Amyloidosis
April 14, 2020
 · 
12 min read
Genetown
Alnylam to Webcast Presentation at 19th Annual Needham Virtual Healthcare Conference
April 13, 2020
 · 
1 min read
Business
Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the Advancement of RNAi Therapeutics
April 13, 2020
 · 
13 min read
Load More